Intra-articular corticosteroid treatment in osteoarthritis

Creamer, Paul

doi:10.1097/00001433-200002000-00012

Cited by 20 publications

(24 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Steroid injections of the hip can be administered for diagnostic [8,11,20,22] and therapeutic reasons [9,28,32,43], particularly to alleviate inflammatory symptoms that can be associated with moderate or end-stage osteoarthritis (OA) of the joint. The radiographic findings of OA are not always conclusive or in relation to the symptoms expressed by the patient.…”

Section: Introductionmentioning

confidence: 99%

“…In conjunction with an intraarticular injection of a long-acting anesthetic, steroids can be used for diagnostic purposes to distinguish intrinsic from extrinsic sources of pain such as that originating in the spine [8,11,20,22]. The duration and efficacy of pain relief then can be indicative of the source of pain [9,28,32,43]. Although steroid injections in the hip are not recommended in the treatment guidelines provided by the American College of Rheumatology for OA of the hip, they can be helpful in clinical practice when patients with moderate or end-stage OA are not willing or suitable to undergo a THA in the short term [2].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Is the Infection Rate in Primary THA Increased After Steroid Injection?

Meermans¹,

Corten²,

Simon³

2012

Clinical Orthopaedics &Amp; Related Research

View full text Add to dashboard Cite

Background Injection of the hip is performed for diagnostic and therapeutic reasons. Articular cartilage deterioration and increased risk of prosthetic infection have been reported with steroid injections. However, the literature contains contradictory reports on an increased risk of infection after a subsequent THA. Questions/PurposesWe asked whether intraarticular steroid injection increased the rate of infection of a subsequent THA. Methods We retrospectively reviewed records of 175 patients in whom intraarticular steroid injections were given under strictly aseptic conditions using a lateral approach within 1 year before THA. These patients were matched with others from our database who had not received an injection for comorbidities, and for American Society of Anesthesiologists score, age, BMI, sex, type of implant, and year of THA.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Is the Infection Rate in Primary THA Increased After Steroid Injection?

Meermans¹,

Corten²,

Simon³

2012

Clinical Orthopaedics &Amp; Related Research

View full text Add to dashboard Cite

show abstract

“…Girls are predominantly affected by acetabular dysplasia, a mild form of congenital dislocation, whereas the other abnormalities more often affect boys. Depending on the severity of the anatomic abnormalities, hip OA occurs either in young adulthood severe abnormalities or middle age mild abnormalities [36][37] . Major injuries to a joint also can produce anatomic abnormalities that leave the joint susceptible to OA.…”

Section: Risk Factors In the Joint Environmentmentioning

confidence: 99%

Aetiological Factors of Osteoarthritis: A Review Update

et al. 2015

View full text Add to dashboard Cite

Osteoarthritis (OA) is no longer considered "degenerative" or "wear and tear" arthritis; rather involves dynamic biomechanical, biochemical and cellular process. Indeed, the joint damage that occurs in OA is the result of active remodeling involving all the joint structures. Although articular cartilage is at the center of change, OA is viewed as a disease of the entire joint. Traditionally, OA has been viewed as an inevitable degenerative condition of the cartilage. It is currently viewed as a biomechanical and biochemical inflammatory disease of the entire joints. Osteoarthritis (OA) is the most common type of arthritis. Its high prevalence, especially in the elderly, and the high rate of disability related to disease make it a leading cause of disability in the elderly. Because of the aging of Western populations and because obesity, a major risk factor, are increasing in prevalence, the occurrence of osteoarthritis is on the rise. In the United States, osteoarthritis prevalence will increase from 66-100% by the year 2020. OA affects certain joints, yet spares others. Commonly affected joints include the cervical and lumbosacral spine, hip, knee, and first metatarsal phalangeal joint (MTP). In the hands, the distal and proximal interphalangeal joints and the base of the thumb are often affected. Usually spared are the wrist, elbow, and ankle.

show abstract

“…Corticosteroids have an anti-inflammatory property of reducing proinflammatory derivatives, such as bradykinin, histamine, prostaglandins, and leukotrienes, 1 and may have antinociceptive effects (a direct stabilizing effect on neural membranes and inhibit C-fiber transmission). 2 Corticosteroids used in subacromial injections vary in types and doses, but little has been reported about their efficacy and acting duration.…”

Section: Cme Inquiriesmentioning

confidence: 99%

Comparison of High- and Low-Dose Corticosteroid in Subacromial Injection for Periarticular Shoulder Disorder: A Randomized, Triple-Blind, Placebo-Controlled Trial

Hong

Moon

et al. 2011

Archives of Physical Medicine and Rehabilitation

View full text Add to dashboard Cite

Shoulder pain accounts for 33.2% of physician office visits for musculoskeletal pain in the United States. The prevalence of shoulder pain is 7% to 27% for adults and is increasing for women and older individuals. The most frequent cause of shoulder pain is subacromial impingement syndrome (SIS), which includes a number of pathological entities: rotator cuff syndrome, tendonitis and bursitis in the shoulder. SIS occurs when the soft tissues of the glenohumeral joint between the coracoacromial arch and the humeral tuberosity are compressed, disturbing the normal slidingmechanism when elevating the arm. Current approaches to treat SIS include conservative management comprising rest (but not immobilization), ice packs, physiotherapy, or NSAIDS, or any combination of these approaches. In some cases, surgical treatment may be considered an option. Accreditation StatementThis journal-based activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the Elsevier Office of Continuing Medical Education (EOCME). The EOCME is accredited by the ACCME to provide continuing medical education (CME) for physicians. Credit Designation StatementThe EOCME designates this journal-based activity for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. All other health care professionals completing continuing education credit for this activity will be issued a certificate of participation. Educational ObjectivesTo support the attainment of knowledge, competence, and performance, the learner should be able to achieve the following objective:1. Describe the evidence-base supporting the effectiveness of corticosteroid injections for subacromial impingement syndrome 2. Demonstrate their ability to develop a treatment plan based on current evidence Planning CommitteeJi Yeon Hong, MD, Seung-Hyun Yoon, MD, PhD, Do Jun Moon, MD, Kyu-Sung Kwack, MD, PhD, Bohyun Joen, MD, Hyun Young Lee, MS, Tania Dickson, PhD. Faculty Profiles & Disclosure InformationAs a sponsor accredited by the ACCME, it is the policy of the EOCME to require the disclosure of anyone who is in a position to control the content of an educational activity. All relevant financial relationships with any commercial interests and/or manufacturers must be disclosed to participants at the beginning of each activity. The faculty of this educational activity discloses the following: JI YEON HONG, MD Department of Physical Medicine and RehabilitationAjou University School of Medicine and Ajou University Hospital, Suwon Republic of Korea Disclosures: Has nothing to disclose. SEUNG-HYUN YOON, MD, PhD Department of Physical Medicine and Rehabilitation Ajou University School of Medicine and Ajou University Hospital, SuwonRepublic of Korea Disclosures: Has nothing to disclose. DO JUN MOON, MDDepartment of Physical Medicine and Rehabilitation Goyang Healings Hospi...

show abstract

Intra-articular corticosteroid treatment in osteoarthritis

Cited by 20 publications

References 29 publications

Is the Infection Rate in Primary THA Increased After Steroid Injection?

Is the Infection Rate in Primary THA Increased After Steroid Injection?

Aetiological Factors of Osteoarthritis: A Review Update

Comparison of High- and Low-Dose Corticosteroid in Subacromial Injection for Periarticular Shoulder Disorder: A Randomized, Triple-Blind, Placebo-Controlled Trial

Contact Info

Product

Resources

About